Davide Chiasserini

6.1k total citations · 1 hit paper
83 papers, 3.5k citations indexed

About

Davide Chiasserini is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Davide Chiasserini has authored 83 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Physiology, 28 papers in Neurology and 23 papers in Molecular Biology. Recurrent topics in Davide Chiasserini's work include Alzheimer's disease research and treatments (29 papers), Parkinson's Disease Mechanisms and Treatments (27 papers) and Dementia and Cognitive Impairment Research (22 papers). Davide Chiasserini is often cited by papers focused on Alzheimer's disease research and treatments (29 papers), Parkinson's Disease Mechanisms and Treatments (27 papers) and Dementia and Cognitive Impairment Research (22 papers). Davide Chiasserini collaborates with scholars based in Italy, Netherlands and United Kingdom. Davide Chiasserini's co-authors include Lucilla Parnetti, Paolo Calabresi, Paolo Eusebi, Tommaso Beccari, Nicola Tambasco, Silvia Paciotti, David Giannandrea, Emanuele Persichetti, Omar M. A. El‐Agnaf and Massimiliano Di Filippo and has published in prestigious journals such as Nature Communications, Blood and Bioinformatics.

In The Last Decade

Davide Chiasserini

80 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay

2024 44 citations Giovanni Bellomo, Federico Paolini Paoletti et al. Alzheimer s & Dementia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davide Chiasserini Italy	31	1.6k	1.4k	1.0k	692	474	83	3.5k
Claudia Schulte Germany	36	2.4k 1.5×	1.3k 0.9×	1.3k 1.2×	777 1.1×	874 1.8×	107	4.3k
Erin H. Norris United States	33	1.6k 1.0×	1.7k 1.2×	1.1k 1.0×	1.3k 1.8×	827 1.7×	58	4.2k
Patrick Oeckl Germany	30	1.3k 0.9×	1.1k 0.7×	1.2k 1.2×	634 0.9×	551 1.2×	86	3.2k
Yasumasa Yoshiyama Japan	28	930 0.6×	2.2k 1.5×	1.1k 1.1×	1.2k 1.7×	1.0k 2.2×	55	3.8k
H. Bea Kuiperij Netherlands	25	742 0.5×	716 0.5×	1.2k 1.2×	359 0.5×	328 0.7×	75	2.5k
Mitsuru Kawai Japan	35	972 0.6×	1.8k 1.2×	1.6k 1.5×	607 0.9×	650 1.4×	129	3.9k
Rita Guerreiro United Kingdom	40	1.9k 1.2×	2.6k 1.8×	1.8k 1.8×	1.7k 2.5×	772 1.6×	130	5.6k
Liisa Myllykangas Finland	28	1.7k 1.1×	1.3k 0.9×	1.0k 1.0×	594 0.9×	527 1.1×	71	3.3k
Kuen‐Jer Tsai Taiwan	28	936 0.6×	744 0.5×	1.1k 1.0×	459 0.7×	360 0.8×	77	2.9k

Countries citing papers authored by Davide Chiasserini

Since Specialization

Citations

This map shows the geographic impact of Davide Chiasserini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Chiasserini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Chiasserini more than expected).

Fields of papers citing papers by Davide Chiasserini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Chiasserini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Chiasserini. The network helps show where Davide Chiasserini may publish in the future.

Co-authorship network of co-authors of Davide Chiasserini

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Chiasserini. A scholar is included among the top collaborators of Davide Chiasserini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Chiasserini. Davide Chiasserini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pieroni, Stefania, Marilena Castelli, Danilo Piobbico, et al.. (2024). HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers. International Journal of Molecular Sciences. 25(9). 4600–4600.

Bellomo, Giovanni, Federico Paolini Paoletti, Yihua Ma, et al.. (2024). Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay. Alzheimer s & Dementia. 20(4). 2444–2452. 44 indexed citations breakdown →

Gatticchi, Leonardo, et al.. (2024). Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities. Biomolecules. 14(1). 137–137. 22 indexed citations

Chatterjee, Madhurima, Marleen J.A. Koel‐Simmelink, Walter Boiten, et al.. (2023). C1q is increased in cerebrospinal fluid‐derived extracellular vesicles in Alzheimer's disease: A multi‐cohort proteomics and immuno‐assay validation study. Alzheimer s & Dementia. 19(11). 4828–4840. 25 indexed citations

Bellomo, Giovanni, et al.. (2023). CSF and plasma Aβ42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa^® assays targeting distinct amyloid regions. Clinical Chemistry and Laboratory Medicine (CCLM). 62(2). 332–340. 8 indexed citations

Manni, Giorgia, Sandra Buratta, Maria Teresa Pallotta, et al.. (2023). Extracellular Vesicles in Aging: An Emerging Hallmark?. Cells. 12(4). 527–527. 28 indexed citations

Chiasserini, Davide, Giovanni Bellomo, Silvia Paciotti, et al.. (2022). Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer’s Disease: ELISA Development and Clinical Validation. Journal of Alzheimer s Disease. 88(4). 1459–1468. 4 indexed citations

Chiasserini, Davide, et al.. (2021). A Prostate Cancer Proteomics Database for SWATH-MS Based Protein Quantification. Cancers. 13(21). 5580–5580. 6 indexed citations

Vignoli, Alessia, Silvia Paciotti, Leonardo Tenori, et al.. (2020). Fingerprinting Alzheimer’s Disease by ¹H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid. Journal of Proteome Research. 19(4). 1696–1705. 33 indexed citations

10.

McGurk, Kathryn A., Arianna Dagliati, Davide Chiasserini, et al.. (2019). The use of missing values in proteomic data-independent acquisition mass spectrometry to enable disease activity discrimination. Bioinformatics. 36(7). 2217–2223. 21 indexed citations

11.

Eusebi, Paolo, Oskar Hansson, Silvia Paciotti, et al.. (2017). Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson’s disease: protocol for a systematic review and individual participant data meta-analysis. BMJ Open. 7(11). e018177–e018177. 4 indexed citations

12.

Majbour, Nour K., Davide Chiasserini, Nishant N. Vaikath, et al.. (2017). Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease. Scientific Reports. 7(1). 40263–40263. 45 indexed citations

13.

Eusebi, Paolo, David Giannandrea, Leonardo Biscetti, et al.. (2016). Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis. BMJ Open. 6(6). e011113–e011113. 12 indexed citations

14.

Cicognola, Claudia, Davide Chiasserini, Paolo Eusebi, et al.. (2016). No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF. Molecular Neurodegeneration. 11(1). 65–65. 15 indexed citations

15.

Chiasserini, Davide, Magdalena Davidescu, Lara Macchioni, et al.. (2016). 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells. Journal of Proteomics. 152. 329–338. 21 indexed citations

16.

Cicognola, Claudia, Davide Chiasserini, & Lucilla Parnetti. (2015). Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Issue of Diurnal Variation. Frontiers in Neurology. 6. 143–143. 21 indexed citations

17.

Bury, Loredana, Emanuela Falcinelli, Davide Chiasserini, et al.. (2015). Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia. Haematologica. 101(1). 46–56. 45 indexed citations

18.

Filippo, Massimiliano Di, Davide Chiasserini, Fabrizio Gardoni, et al.. (2013). Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiology of Disease. 52. 229–236. 155 indexed citations

19.

Chiasserini, Davide, Alessandro Tozzi, Antonio de Iure, et al.. (2011). Mortalin inhibition in experimental Parkinson's disease. Movement Disorders. 26(9). 1639–1647. 22 indexed citations

20.

Filippo, Massimiliano Di, Davide Chiasserini, Alessandro Tozzi, Barbara Picconi, & Paolo Calabresi. (2010). Mitochondria and the Link Between Neuroinflammation and Neurodegeneration. Journal of Alzheimer s Disease. 20(s2). S369–S379. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact